Kabeya Kenji, Satoh Hiroki, Hori Satoko, Miura Yasumasa, Sawada Yasufumi
Faculty of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
Laboratory of Drug Lifetime Management, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo 113-0033, Japan.
Patient Prefer Adherence. 2020 Jul 27;14:1267-1274. doi: 10.2147/PPA.S254040. eCollection 2020.
Press-through-package (PTP) sheets are common forms of packaging for medicines in Japan. However, patients and/or pharmacists have reported difficulty in extracting tablets or capsules from some PTP sheets.
We used postmarketing surveillance data to identify the characteristics of PTP sheets that patients and pharmacists feel are "hard to use".
Marketing specialists of Toho Pharmaceutical Co., Ltd. canvassed patients and medical workers during November 2014-April 2016. Among 1,129 anonymous reports of products being "hard to use", we identified 39 products with 5 or more reports (Problem group). We compared the sizes of the drugs and PTP pockets, the size ratio, the material used for the front of PTPs, the shape of the pockets, the thickness of the pocket wall, and the force needed to release the drug from the PTP (press-out force: POF) in this Problem group with those in a Control group of 97 problem-free products.
Logistic regression analyses revealed that a bigger pocket, a smaller drug size and a smaller drug-pocket size ratio increase the risk of being "hard to use". Regarding the material, aluminum, PCTFE and PE increase the risk, while PP and PVC decrease the risk. Other factors had no significant influence.
Pockets in PTP sheets should be designed so as to minimize the gap between the drug and the pocket, and PP or PVC should be used as the front material instead of aluminum, PCTFE or PE. Our results suggest that marketing specialists can play effective roles in postmarketing surveillance.
在日本,压穿式包装(PTP)薄片是药品常见的包装形式。然而,患者和/或药剂师报告称,从某些PTP薄片中取出片剂或胶囊存在困难。
我们利用上市后监测数据,确定患者和药剂师认为“难以使用”的PTP薄片的特征。
东邦制药有限公司的市场专员在2014年11月至2016年4月期间对患者和医疗工作者进行了调查。在1129份关于产品“难以使用”的匿名报告中,我们确定了有5份或更多报告的39种产品(问题组)。我们将该问题组的药物和PTP口袋的尺寸、尺寸比、PTP正面使用的材料、口袋形状、口袋壁厚度以及从PTP中取出药物所需的力(压出力:POF)与97种无问题产品的对照组进行了比较。
逻辑回归分析显示,口袋较大、药物尺寸较小以及药物与口袋的尺寸比减小会增加“难以使用”的风险。关于材料,铝、聚三氟氯乙烯和聚乙烯会增加风险,而聚丙烯和聚氯乙烯会降低风险。其他因素没有显著影响。
PTP薄片中的口袋设计应尽量减小药物与口袋之间的间隙,并且应使用聚丙烯或聚氯乙烯作为正面材料,而不是铝、聚三氟氯乙烯或聚乙烯。我们的结果表明,市场专员在上市后监测中可以发挥有效作用。